Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

J. Anderson, Lisa; A. Westwood, Mark; Holden, Sally; Davis, Bernard; Prescott, Emma; Wonke, Beatrix; B. Porter, John; Malcolm Walker, J.; J. Pennell, Dudley

doi:10.1111/j.1365-2141.2004.05202.x

Public

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

Shared by NobleBlocks on Oct 18, 2004 • 12:00 AM UTC

Authors:

Lisa J. Anderson

Mark A. Westwood

Sally Holden

Abstract

Summary Heart failure from iron overload causes 71% of deaths in thalassaemia major, yet reversal of siderotic cardiomyopathy has been reported. In order to determine the changes in myocardial iron during treatment, we prospectively followed thalassaemia patients commencing intravenous desferrioxami...

Discussions